Omer Kucuk, MD

One star
One star
One star
One star
One half star

Rating: 4.9 out of 5 (484 ratings)

Role

Medical Oncology
Specialty

Prostate Cancer Bladder Cancer Kidney (Renal) Cancer Penile Cancer Testicular Cancer
Research Program

Cancer Prevention and Control
Practicing Since

1981

Request Appointment

Background

Omar Kucuk, MD brings to Emory an impressive track record of groundbreaking research in cancer prevention through nutritional components. He has been conducting clinical trials with lycopene and soy isoflavones in combination with standard therapy for prostate cancer since 1996. Nutrition and cancer therapy is Dr. Kucuk's primary research focus.

Carotenoids, isoflavones, zinc, selenium, and folic acid are among the cancer-preventing compounds found in vegetables and fruits, says Dr. Kucuk. Our current investigations focus on the effects of micronutrients and phytochemicals on biomarkers of cell growth, differentiation, inflammation and oxidative stress in a variety of cancers.

Dr. Kucuk conducted the first clinical trials with lycopene and soy isoflavones in prostate cancer and was the first to report the benefits of lycopene and soy isoflavones in the treatment of prostate cancer patients. He reported that lycopene and soy isoflavones have efficacy in patients with hormone-naïve as well as hormone-refractory prostate cancer.

He was the first to report the sensitization of prostate cancer cells to chemotherapy and radiation therapy by soy isoflavones and the first to report that soy isoflavones prevent the adverse effects of radiation in prostate cancer patients.

These studies were done in collaboration with other investigators at Karmanos Cancer Institute and Wayne State University, Detroit, Michigan. Future studies at Emory Winship Cancer Institute will continue to investigate the role of soy isoflavones and other nutritional compounds alone or in combination with chemotherapy and radiation in the treatment of prostate cancer.

Dr. Kucuk is conducting innovative clinical trials to investigate new approaches to prostate and bladder cancer therapy using combinations of chemotherapy, radiation therapy and nutritional agents.

He has also been very active internationally with collaborative research projects and international conferences conducted with scientists in Turkey, Israel, Brazil, Canada, and Norway. He organized the First International Congress on Nutrition and Cancer in Antalya, Turkey in May 2008. He was also the first to report that dietary lycopene intake prevents kidney cancer in Eker rat, ovarian cancer in laying hen and leiomyoma in the Japanese quail in collaboration with veterinary researchers at Firat University, Elazig, Turkey.

Titles & Roles

Professor and Correll Chair in Genitourinary Cancer, Department of Hematology and Medical Oncology

Emory University School of Medicine

Education & Training

Education

Fellowship, Hematology & Oncology, 1981
Northwestern Feinberg School of Medicine
Fellowship, Hematology & Oncology, 1980
St. Francis Hospital - Evanston
Residency, Internal Medicine, 1978
St. Francis Hospital - Evanston
Internship, Internal Medicine, 1976
St. Francis Hospital - Evanston
Medical Education, , 1975
Hacettepe University

Board Certifications

Medical Oncology
American Board of Internal Medicine, 1989
Hematology
American Board of Internal Medicine, 1984
Internal Medicine
American Board of Internal Medicine, 1978

Professional Memberships

American Association for Cancer Research
American Society of Clinical Oncology
American Urological Association
Society of Basic Urological Research
Society of Integrative Oncology
Academic Consortium for Integrative Medicine and Health

Title/Journal	Authors	Publication Date
Comprehensive genomic profiling of penile squamous cell carcinoma and the impact of human papillomavirus status on immune-checkpoint inhibitor-related biomarkers. Cancer	B Nazha, T Zhuang, S Wu, JT Brown, D Magee, BC Carthon, O Kucuk, C Nabhan, PC Barata, EI Heath, CJ Ryan, RR McKay, VA Master, MA Bilen	15/12/2023
Immune-Related Adverse Events and Clinical Outcomes in Advanced Urothelial Cancer Patients Treated With Immune Checkpoint Inhibitors. The oncologist	GE Sanda, JM Shabto, S Goyal, Y Liu, DJ Martini, B Nazha, JT Brown, LB Yantorni, G Anne Russler, S Caulfield, SS Joshi, VM Narayan, H Kissick, K Ogan, VA Master, BC Carthon, O Kucuk, MA Bilen	11/12/2023
Is vitamin A an antioxidant? International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition	T Bohn, V Böhm, J Dulińska-Litewka, JF Landrier, D Bánáti, O Kucuk, P Borel, JA Canas, R Rühl	01/12/2023
Nicardipine is a putative EED inhibitor and has high selectivity and potency against chemoresistant prostate cancer in preclinical models. British journal of cancer	X Li, Y Chen, L Bai, R Zhao, Y Wu, ZR Xie, JM Wu, NJ Bowen, A Danaher, N Cook, D Li, M Qui, Y Du, H Fu, AO Osunkoya, O Kucuk, D Wu	01/09/2023
Bromocriptine monotherapy overcomes prostate cancer chemoresistance in preclinical models. Translational oncology	L Bai, X Li, Y Yang, R Zhao, EZ White, A Danaher, NJ Bowen, CV Hinton, N Cook, D Li, AY Wu, M Qui, Y Du, H Fu, O Kucuk, D Wu	01/08/2023
Lycopene in Prevention of Infertility After Testicular Surgery Regarding Urology. 2022;164:267-272. doi:10.1016/j.urology.2021.11.044. Urology	O Kucuk	01/05/2023
Impact of 18 F-Fluciclovine PET/CT Findings on Failure-Free Survival in Biochemical Recurrence of Prostate Cancer Following Salvage Radiation Therapy. Clinical nuclear medicine	IO Lawal, C Marcus, DM Schuster, S Goyal, OA Adediran, VR Dhere, SS Joshi, OA Abiodun-Ojo, VA Master, PR Patel, B Fielder, M Goodman, JW Shelton, O Kucuk, B Hershatter, RK Halkar, AB Jani	01/04/2023
Treatment Response to Lycopene in Recurrent Prostate Cancer Confirmed on 18 F-Fluciclovine PET/CT. Clinical nuclear medicine	C Wu, C Marcus, Y Baum, O Kucuk, DM Schuster	01/04/2023
Differences in Failure-Free Survival After Salvage Radiotherapy Guided by Conventional Imaging Versus ¹⁸F-Fluciclovine PET/CT in Postprostatectomy Patients: A Post Hoc Substratification Analysis of the EMPIRE-1 Trial. Journal of nuclear medicine : official publication, Society of Nuclear Medicine	IO Lawal, AB Jani, OA Adediran, S Goyal, OA Abiodun-Ojo, VR Dhere, CV Marcus, SS Joshi, VA Master, PR Patel, M Goodman, JW Shelton, O Kucuk, B Hershatter, B Fielder, RK Halkar, DM Schuster	01/04/2023
Baseline Neutrophil-to-Eosinophil Ratio Is Associated with Outcomes in Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors. The oncologist	TZ Zhuang, D Ravindranathan, Y Liu, DJ Martini, JT Brown, B Nazha, G Russler, LB Yantorni, S Caulfield, BC Carthon, O Kucuk, VA Master, MA Bilen	17/03/2023
Modulation of inflammation by phytochemicals to enhance efficacy and reduce toxicity of cancer chemotherapy. Critical reviews in food science and nutrition	TK Sahin, B Bilir, O Kucuk	01/01/2023
Prognostic Evaluation of Metastatic Castration Resistant Prostate Cancer and Neuroendocrine Prostate Cancer with [⁶⁸Ga]Ga DOTATATE PET-CT. Cancers	MA Bilen, A Akintayo, Y Liu, O Abiodun-Ojo, O Kucuk, BC Carthon, DM Schuster, EE Parent	08/12/2022
Walk More, Eat Less, Don't Stress. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology	O Kucuk	02/09/2022
Combination Immune Checkpoint Blockade Regimens for Previously Untreated Metastatic Renal Cell Carcinoma: The Winship Cancer Institute of Emory University Experience. Journal of immunotherapy and precision oncology	DJ Martini, TA Olsen, S Goyal, Y Liu, ST Evans, EE Hitron, GA Russler, L Yantorni, S Caulfield, JT Brown, JM Goldman, B Nazha, BC Carthon, WB Harris, O Kucuk, VA Master, MA Bilen	01/08/2022
Clinical outcome following checkpoint therapy in renal cell carcinoma is associated with a burst of activated CD8 T cells in blood. Journal for immunotherapy of cancer	JW Carlisle, CS Jansen, MA Cardenas, E Sobierajska, AM Reyes, R Greenwald, L Del Balzo, N Prokhnevska, O Kucuk, BC Carthon, PC Mullane, A Osunkoya, D Baumgarten, F Hosseinzadeh, S Wilkinson, R Lake, AG Sowalsky, Y Liu, VA Master, MA Bilen, H Kissick	01/07/2022
High throughput, label-free isolation of circulating tumor cell clusters in meshed microwells. Nature communications	M Boya, T Ozkaya-Ahmadov, BE Swain, CH Chu, N Asmare, O Civelekoglu, R Liu, D Lee, S Tobia, S Biliya, LD McDonald, B Nazha, O Kucuk, MG Sanda, BB Benigno, CS Moreno, MA Bilen, JF McDonald, AF Sarioglu	13/06/2022
Metastatic Clear-Cell Renal Cell Carcinoma in the Era of Immune Checkpoint Inhibitors: Therapies and Ongoing Trials. Cancers	TZ Zhuang, K Case, TA Olsen, JT Brown, BC Carthon, O Kucuk, J Goldman, W Harris, MA Bilen, B Nazha	10/06/2022
Blood-Based Next-Generation Sequencing in Adrenocortical Carcinoma. The oncologist	B Nazha, TZ Zhuang, HI Dada, LM Drusbosky, JT Brown, D Ravindranathan, BC Carthon, O Kucuk, J Goldman, VA Master, MA Bilen	08/06/2022
Baseline basophil and basophil-to-lymphocyte status is associated with clinical outcomes in metastatic hormone sensitive prostate cancer. Urologic oncology	A Hadadi, KE Smith, L Wan, JR Brown, G Russler, L Yantorni, S Caulfield, J Lafollette, M Moore, O Kucuk, B Carthon, B Nazha, Y Liu, MA Bilen	01/06/2022
Analysis of Toxicity and Clinical Outcomes in Full Versus Reduced Starting Dose Cabozantinib in Metastatic Renal Cell Carcinoma Patients. Clinical genitourinary cancer	DJ Martini, ST Evans, Y Liu, JM Shabto, OE Uner, TA Olsen, JT Brown, GA Russler, L Yantorni, S Caulfield, JM Goldman, B Nazha, WB Harris, VA Master, O Kucuk, BC Carthon, MA Bilen	01/02/2022
Advances in Knowledge and Management of Immune-Related Adverse Events in Cancer Immunotherapy. Frontiers in endocrinology	TA Olsen, TZ Zhuang, S Caulfield, DJ Martini, JT Brown, BC Carthon, O Kucuk, W Harris, MA Bilen, B Nazha	01/01/2022
Durable complete response for oligometastatic renal cell carcinoma with immune checkpoint inhibition and cytoreductive nephrectomy in a Jehovah's witness: A case report. Frontiers in oncology	TZ Zhuang, L Harik, S Force, A Hadadi, MA Bilen, JT Brown, BC Carthon, J Goldman, O Kucuk, VA Master, B Nazha	01/01/2022
Overcoming prostate cancer drug resistance with a novel organosilicon small molecule. Neoplasia (New York, N.Y.)	R Zhao, X Ma, L Bai, X Li, K Mamouni, Y Yang, H Liu, A Danaher, N Cook, O Kucuk, RS Hodges, L Gera, D Wu	01/12/2021
Body Composition as an Independent Predictive and Prognostic Biomarker in Advanced Urothelial Carcinoma Patients Treated with Immune Checkpoint Inhibitors. The oncologist	DJ Martini, JM Shabto, S Goyal, Y Liu, TA Olsen, ST Evans, BL Magod, D Ravindranathan, JT Brown, L Yantorni, GA Russler, S Caulfield, JM Goldman, B Nazha, SS Joshi, HT Kissick, KE Ogan, WB Harris, O Kucuk, BC Carthon, VA Master, MA Bilen	01/12/2021
Clinical Outcomes and Racial Disparities in Metastatic Hormone-Sensitive Prostate Cancer in the Era of Novel Treatment Options. The oncologist	KER Smith, JT Brown, L Wan, Y Liu, G Russler, L Yantorni, S Caulfield, J Lafollette, M Moore, O Kucuk, B Carthon, B Nazha, MA Bilen	01/11/2021
Negative enrichment of circulating tumor cells from unmanipulated whole blood with a 3D printed device. Scientific reports	CH Chu, R Liu, T Ozkaya-Ahmadov, BE Swain, M Boya, B El-Rayes, M Akce, MA Bilen, O Kucuk, AF Sarioglu	18/10/2021
Immune-Related Adverse Events as Clinical Biomarkers in Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors. The oncologist	DJ Martini, S Goyal, Y Liu, ST Evans, TA Olsen, K Case, BL Magod, JT Brown, L Yantorni, GA Russler, S Caulfield, JM Goldman, B Nazha, WB Harris, HT Kissick, VA Master, O Kucuk, BC Carthon, MA Bilen	01/10/2021
EDITORIAL COMMENT. Urology	O Kucuk	01/10/2021
Small-Cell Carcinoma of the Prostate: Report of Outcomes of Localized Disease Using the National Cancer Database. Clinical genitourinary cancer	KM Xu, Y Liu, TW Gillespie, AO Osunkoya, B Carthon, MA Bilen, CP Filson, K Ogan, PR Patel, JW Shelton, O Kucuk, S Joshi, AB Jani	01/08/2021
Epigenetic alterations and genetic variations of angiotensin-converting enzyme 2 (ACE2) as a functional receptor for SARS-CoV-2: potential clinical implications. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology	A Kianmehr, I Faraoni, O Kucuk, A Mahrooz	01/08/2021
IL-7 expands lymphocyte populations and enhances immune responses to sipuleucel-T in patients with metastatic castration-resistant prostate cancer (mCRPC). Journal for immunotherapy of cancer	RK Pachynski, C Morishima, R Szmulewitz, L Harshman, L Appleman, P Monk, RL Bitting, O Kucuk, F Millard, JD Seigne, SP Fling, HT Maecker, C Duault, N Ramchurren, B Hess, L D'Amico, A Lacroix, JC Kaiser, M Morre, A Grégoire, M Cheever, EY Yu, L Fong	01/08/2021
Modified Glasgow Prognostic Score associated with survival in metastatic renal cell carcinoma treated with immune checkpoint inhibitors. Journal for immunotherapy of cancer	JT Brown, Y Liu, JM Shabto, D Martini, D Ravindranathan, EE Hitron, GA Russler, S Caulfield, L Yantorni, SS Joshi, H Kissick, K Ogan, B Nazha, BC Carthon, O Kucuk, WB Harris, VA Master, MA Bilen	01/07/2021
¹⁸F-fluciclovine-PET/CT imaging versus conventional imaging alone to guide postprostatectomy salvage radiotherapy for prostate cancer (EMPIRE-1): a single centre, open-label, phase 2/3 randomised controlled trial. Lancet (London, England)	AB Jani, E Schreibmann, S Goyal, R Halkar, B Hershatter, PJ Rossi, JW Shelton, PR Patel, KM Xu, M Goodman, VA Master, SS Joshi, O Kucuk, BC Carthon, MA Bilen, OA Abiodun-Ojo, AA Akintayo, VR Dhere, DM Schuster	22/05/2021
Baseline Modified Glasgow Prognostic Score Associated with Survival in Metastatic Urothelial Carcinoma Treated with Immune Checkpoint Inhibitors. The oncologist	JT Brown, Y Liu, JM Shabto, DJ Martini, D Ravindranathan, EE Hitron, GA Russler, S Caulfield, LB Yantorni, SS Joshi, H Kissick, K Ogan, WB Harris, BC Carthon, O Kucuk, VA Master, MA Bilen	01/05/2021
Acetylation of KLF5 maintains EMT and tumorigenicity to cause chemoresistant bone metastasis in prostate cancer. Nature communications	B Zhang, Y Li, Q Wu, L Xie, B Barwick, C Fu, X Li, D Wu, S Xia, J Chen, WP Qian, L Yang, AO Osunkoya, L Boise, PM Vertino, Y Zhao, M Li, HR Chen, J Kowalski, O Kucuk, W Zhou, JT Dong	17/03/2021
Centrosome amplification: a quantifiable cancer cell trait with prognostic value in solid malignancies. Cancer metastasis reviews	K Mittal, J Kaur, M Jaczko, G Wei, MS Toss, EA Rakha, EAM Janssen, H Søiland, O Kucuk, MD Reid, MV Gupta, R Aneja	01/03/2021
Epithelial protein lost in neoplasm (EPLIN) and prostate cancer: lessons learned from the ARCaP model. American journal of clinical and experimental urology	D Wu, AO Osunkoya, O Kucuk	01/01/2021
Exploratory study of ¹⁸F-fluciclovine pet/ct for response assessment to docetaxel in patients with metastatic castration-resistant prostate cancer. American journal of nuclear medicine and molecular imaging	AA Akintayo, MA Bilen, OA Abiodun-Ojo, O Kucuk, B Carthon, Z Chen, AB Jani, EE Parent, DM Schuster	01/01/2021
Novel risk scoring system for metastatic renal cell carcinoma patients treated with cabozantinib. Cancer treatment and research communications	DJ Martini, MR Kline, Y Liu, JM Shabto, BC Carthon, GA Russler, L Yantorni, EE Hitron, S Caulfield, JM Goldman, WB Harris, O Kucuk, VA Master, MA Bilen	01/01/2021
Bladder preserving chemoradiotherapy compared to surgery for variants of urothelial carcinoma and other tumors types involving the bladder: An analysis of the National Cancer Database. Clinical and translational radiation oncology	JR Janopaul-Naylor, J Zhong, Y Liu, C Zhang, AO Osunkoya, SS Joshi, MA Bilen, B Carthon, O Kucuk, LM Hartsell, J Shelton, AB Jani	01/01/2021
Body Composition Variables as Radiographic Biomarkers of Clinical Outcomes in Metastatic Renal Cell Carcinoma Patients Receiving Immune Checkpoint Inhibitors. Frontiers in oncology	DJ Martini, TA Olsen, S Goyal, Y Liu, ST Evans, B Magod, JT Brown, L Yantorni, GA Russler, S Caulfield, JM Goldman, B Nazha, HT Kissick, WB Harris, O Kucuk, BC Carthon, VA Master, MA Bilen	01/01/2021
Racial Differences in Clinical Outcomes for Metastatic Renal Cell Carcinoma Patients Treated With Immune-Checkpoint Blockade. Frontiers in oncology	TA Olsen, DJ Martini, S Goyal, Y Liu, ST Evans, B Magod, JT Brown, L Yantorni, GA Russler, S Caulfield, JM Goldman, WB Harris, O Kucuk, BC Carthon, VA Master, B Nazha, MA Bilen	01/01/2021
Awareness, Use and Outlook of Complementary and Alternative Medicine (CAM) Options in an Underserved, Uninsured Minority Cancer Patient Population. Integrative cancer therapies	S Bari, I Chineke, A Darwin, A Umar, H Jim, J Muzaffar, S Singh, O Kucuk	01/01/2021
Pharmacological inhibition of noncanonical EED-EZH2 signaling overcomes chemoresistance in prostate cancer. Theranostics	X Li, L Gera, S Zhang, Y Chen, L Lou, LM Wilson, ZR Xie, G Sautto, D Liu, A Danaher, K Mamouni, Y Yang, Y Du, H Fu, O Kucuk, AO Osunkoya, J Zhou, D Wu	01/01/2021
Initial Report of a Randomized Trial Comparing Conventional- vs Conventional plus Fluciclovine (¹⁸F) PET/CT Imaging-Guided Post-Prostatectomy Radiotherapy for Prostate Cancer. International journal of radiation oncology, biology, physics	A Jani, E Schreibmann, S Goyal, H Raghuveer, B Hershatter, PJ Rossi, JW Shelton, PR Patel, KM Xu, M Goodman, V Master, SS Joshi, O Kucuk, B Carthon, MA Bilen, S Cooper, B Fielder, O Abiodun-Ojo, VR Dhere, DM Schuster	01/12/2020
Kinless hubs are potential target genes in prostate cancer network. Genomics	IR Mangangcha, MZ Malik, O Kucuk, S Ali, RKB Singh	01/11/2020
Novel small-molecule LG1836 inhibits the in vivo growth of castration-resistant prostate cancer. The Prostate	Y Chen, X Li, K Mamouni, Y Yang, A Danaher, J White, H Liu, O Kucuk, L Gera, D Wu	01/09/2020
Novel risk group stratification for metastatic urothelial cancer patients treated with immune checkpoint inhibitors. Cancer medicine	JM Shabto, DJ Martini, Y Liu, D Ravindranathan, J Brown, EE Hitron, GA Russler, S Caulfield, H Kissick, M Alemozaffar, K Ogan, WB Harris, VA Master, O Kucuk, BC Carthon, MA Bilen	01/04/2020
Novel Risk Scoring System for Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors. The oncologist	DJ Martini, Y Liu, JM Shabto, BC Carthon, EE Hitron, GA Russler, S Caulfield, HT Kissick, WB Harris, O Kucuk, VA Master, MA Bilen	01/03/2020
Overall survival comparison between androgen deprivation therapy (ADT) plus external beam radiation therapy (EBRT) vs ADT plus EBRT with brachytherapy boost in clinically node-positive prostate cancer. Brachytherapy	BW Fischer-Valuck, YJ Rao, RJ Brenneman, PR Patel, CP Filson, AB Jani, Y Liu, S Goyal, K Xu, A Weiss, O Kucuk, C Cimmino, S Szabo, P Rossi, BC Baumann, J Pattaras, B Hershatter, SA Patel	01/01/2020
Neoadjuvant Cabozantinib in an Unresectable Locally Advanced Renal Cell Carcinoma Patient Leads to Downsizing of Tumor Enabling Surgical Resection: A Case Report. Frontiers in oncology	MA Bilen, JF Jiang, CS Jansen, JT Brown, LR Harik, A Sekhar, H Kissick, SK Maithel, O Kucuk, B Carthon, VA Master	01/01/2020
TGF-β causes Docetaxel resistance in Prostate Cancer via the induction of Bcl-2 by acetylated KLF5 and Protein Stabilization. Theranostics	Y Li, B Zhang, L Xiang, S Xia, O Kucuk, X Deng, LH Boise, JT Dong	01/01/2020
Identification of key regulators in prostate cancer from gene expression datasets of patients. Scientific reports	IR Mangangcha, MZ Malik, Ö Küçük, S Ali, RKB Singh	11/11/2019
Cetuximab and methotrexate in recurrent or metastatic head and neck squamous cell carcinoma-A single institution analysis of 54 patients. Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery	A Sukari, M Nagasaka, M Diab, K Al Sibai, B Atassi, JA Elayoubi, S Kim, Ö Küçük	01/07/2019
Small molecule BKM1972 inhibits human prostate cancer growth and overcomes docetaxel resistance in intraosseous models. Cancer letters	Y Chen, L Gera, S Zhang, X Li, Y Yang, K Mamouni, AY Wu, H Liu, O Kucuk, D Wu	01/04/2019
Genistein Prevents Development of Spontaneous Ovarian Cancer and Inhibits Tumor Growth in Hen Model. Cancer prevention research (Philadelphia, Pa.)	K Sahin, E Yenice, B Bilir, C Orhan, M Tuzcu, N Sahin, IH Ozercan, N Kabil, B Ozpolat, O Kucuk	01/03/2019
Comparison of Outcomes in Patients With Muscle-invasive Bladder Cancer Treated With Radical Cystectomy Versus Bladder Preservation. American journal of clinical oncology	J Zhong, J Switchenko, NK Jegadeesh, RJ Cassidy, TW Gillespie, V Master, P Nieh, M Alemozaffar, O Kucuk, B Carthon, CP Filson, MA Bilen, AB Jani	01/01/2019
Soy Isoflavones in Integrative Oncology: Increased Efficacy and Decreased Toxicity of Cancer Therapy. Integrative cancer therapies	I Sahin, B Bilir, S Ali, K Sahin, O Kucuk	01/01/2019
Tomato Powder Modulates NF-κB, mTOR, and Nrf2 Pathways during Aging in Healthy Rats. Journal of aging research	K Sahin, C Orhan, M Tuzcu, H Tastan, B Bilir, N Sahin, DA Oner, O Kucuk	01/01/2019
Bladder Preservation With Twice-a-Day Radiation Plus Fluorouracil/Cisplatin or Once Daily Radiation Plus Gemcitabine for Muscle-Invasive Bladder Cancer: NRG/RTOG 0712-A Randomized Phase II Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology	JJ Coen, P Zhang, PJ Saylor, CT Lee, CL Wu, W Parker, T Lautenschlaeger, AL Zietman, JA Efstathiou, AB Jani, O Kucuk, L Souhami, JP Rodgers, HM Sandler, WU Shipley	01/01/2019
Soy Isoflavone Supplementation Increases Long Interspersed Nucleotide Element-1 (LINE-1) Methylation in Head and Neck Squamous Cell Carcinoma. Nutrition and cancer	LS Rozek, S Virani, EL Bellile, JMG Taylor, MA Sartor, KR Zarins, A Virani, C Cote, FP Worden, MEP Mark, SA McLean, SA Duffy, GH Yoo, NF Saba, DM Shin, O Kucuk, GT Wolf	01/01/2019
Effect of Increasing Levels of Web-Based Behavioral Support on Changes in Physical Activity, Diet, and Symptoms in Men With Prostate Cancer: Protocol for a Randomized Controlled Trial. JMIR research protocols	KM Winters-Stone, SA Kenfield, EL Van Blarigan, EL Moe, JW Ramsdill, K Daniel, G Macaire, K Paich, ER Kessler, O Kucuk, TW Gillespie, KS Lyons, TM Beer, JM Broering, PR Carroll, JM Chan	15/11/2018
The addition of chemotherapy in the definitive management of high risk prostate cancer. Urologic oncology	MJ Ferris, Y Liu, J Ao, J Zhong, M Abugideiri, TW Gillespie, BC Carthon, MA Bilen, O Kucuk, AB Jani	01/11/2018
Repositioning Dopamine D2 Receptor Agonist Bromocriptine to Enhance Docetaxel Chemotherapy and Treat Bone Metastatic Prostate Cancer. Molecular cancer therapeutics	Y Yang, K Mamouni, X Li, Y Chen, S Kavuri, Y Du, H Fu, O Kucuk, D Wu	01/09/2018
A Novel Flavonoid Composition Targets Androgen Receptor Signaling and Inhibits Prostate Cancer Growth in Preclinical Models. Neoplasia (New York, N.Y.)	K Mamouni, S Zhang, X Li, Y Chen, Y Yang, J Kim, MG Bartlett, IM Coleman, PS Nelson, O Kucuk, D Wu	01/08/2018
Association Between Pretreatment Neutrophil-to-Lymphocyte Ratio and Outcome of Patients With Metastatic Renal-Cell Carcinoma Treated With Nivolumab. Clinical genitourinary cancer	MA Bilen, GMA Dutcher, Y Liu, D Ravindranathan, HT Kissick, BC Carthon, O Kucuk, WB Harris, VA Master	01/06/2018
Design, synthesis, and evaluation of the antiproliferative activity of hydantoin-derived antiandrogen-genistein conjugates. Bioorganic & medicinal chemistry	A George, I Raji, B Cinar, O Kucuk, AK Oyelere	01/05/2018
Lycopene Protects Against Spontaneous Ovarian Cancer Formation in Laying Hens. Journal of cancer prevention	K Sahin, E Yenice, M Tuzcu, C Orhan, C Mizrak, IH Ozercan, N Sahin, B Yilmaz, B Bilir, B Ozpolat, O Kucuk	01/03/2018
Chemopreventive and Antitumor Efficacy of Curcumin in a Spontaneously Developing Hen Ovarian Cancer Model. Cancer prevention research (Philadelphia, Pa.)	K Sahin, C Orhan, M Tuzcu, N Sahin, H Tastan, İH Özercan, O Güler, N Kahraman, O Kucuk, B Ozpolat	01/01/2018
Mifepristone Has Limited Activity to Enhance the In Vivo Efficacy of Docetaxel and Enzalutamide Against Bone Metastatic and Castration-Resistant Prostate Cancer. Anticancer research	Y Yang, X Li, K Mamouni, O Kucuk, D Wu	01/11/2017
A Comprehensive Definition for Integrative Oncology. Journal of the National Cancer Institute. Monographs	CM Witt, LG Balneaves, MJ Cardoso, L Cohen, H Greenlee, P Johnstone, Ö Kücük, J Mailman, JJ Mao	01/11/2017
A novel preoperative inflammatory marker prognostic score in patients with localized and metastatic renal cell carcinoma. Asian journal of urology	RR Sekar, D Patil, Y Baum, J Pearl, A Bausum, MA Bilen, O Kucuk, WB Harris, BC Carthon, M Alemozaffar, CP Filson, JG Pattaras, PT Nieh, K Ogan, VA Master	01/10/2017
Effects of genistein supplementation on genome‑wide DNA methylation and gene expression in patients with localized prostate cancer. International journal of oncology	B Bilir, NV Sharma, J Lee, B Hammarstrom, A Svindland, O Kucuk, CS Moreno	01/07/2017
Soy foods, isoflavones, and breast cancer. Cancer	O Kucuk	01/06/2017
Time-dependent effects of prognostic biomarkers of systemic inflammation in patients with metastatic renal cell carcinoma. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine	WB Harris, C Zhang, Y Liu, DK Robertson, MY Akbashev, BM Lingerfelt, O Kucuk, BC Carthon, TW Gillespie, AO Osunkoya, VA Master	01/06/2017
Treatment of men with high-risk prostate cancer based on race, insurance coverage, and access to advanced technology. Urologic oncology	RS Gerhard, D Patil, Y Liu, K Ogan, M Alemozaffar, AB Jani, ON Kucuk, VA Master, TW Gillespie, CP Filson	01/05/2017
Impact of ¹⁸F-Fluciclovine PET on Target Volume Definition for Postprostatectomy Salvage Radiotherapy: Initial Findings from a Randomized Trial. Journal of nuclear medicine : official publication, Society of Nuclear Medicine	AB Jani, E Schreibmann, PJ Rossi, J Shelton, K Godette, P Nieh, VA Master, O Kucuk, M Goodman, R Halkar, S Cooper, Z Chen, DM Schuster	01/03/2017
The role of adjuvant radiotherapy in pathologically lymph node-positive prostate cancer. Cancer	N Jegadeesh, Y Liu, C Zhang, J Zhong, RJ Cassidy, T Gillespie, O Kucuk, P Rossi, VA Master, M Alemozaffar, AB Jani	01/02/2017
Comparable outcomes following two or three cycles of high-dose chemotherapy and autologous stem cell transplantation for patients with relapsed/refractory germ cell tumors. Bone marrow transplantation	Z DeFilipp, CB Rosand, DA Goldstein, VA Master, BC Carthon, WB Harris, O Kucuk, Z Al-Kadhimi, JB Cohen, CR Flowers, MJ Lechowicz, AK Nooka, JL Kaufman, AA Langston, Z Chen, J Arora, EK Waller	01/01/2017
Lycopene in the Prevention of Radiation-Induced Esophagitis. Nutrition and cancer	H Coskun, F Andic, YK Daglıoglu, F Doran, K Sahin, C Tunalı, O Kucuk	01/01/2017
Ginger augmented chemotherapy: A novel multitarget nontoxic approach for cancer management. Molecular nutrition & food research	R Saxena, PC Rida, O Kucuk, R Aneja	01/06/2016
Inhibition of skeletal growth of human prostate cancer by the combination of docetaxel and BKM1644: an aminobisphosphonate derivative. Oncotarget	S Zhang, L Gera, K Mamouni, X Li, Z Chen, O Kucuk, D Wu	10/05/2016
How to be good at being bad: centrosome amplification and mitotic propensity drive intratumoral heterogeneity. Cancer metastasis reviews	PC Rida, G Cantuaria, MD Reid, O Kucuk, R Aneja	01/12/2015
Designing a broad-spectrum integrative approach for cancer prevention and treatment. Seminars in cancer biology	KI Block, C Gyllenhaal, L Lowe, A Amedei, ARMR Amin, A Amin, K Aquilano, J Arbiser, A Arreola, A Arzumanyan, SS Ashraf, AS Azmi, F Benencia, D Bhakta, A Bilsland, A Bishayee, SW Blain, PB Block, CS Boosani, TE Carey, A Carnero, M Carotenuto, SC Casey, M Chakrabarti, R Chaturvedi, GZ Chen, H Chen, S Chen, YC Chen, BK Choi, MR Ciriolo, HM Coley, AR Collins, M Connell, S Crawford, CS Curran, C Dabrosin, G Damia, S Dasgupta, RJ DeBerardinis, WK Decker, P Dhawan, AME Diehl, JT Dong, QP Dou, JE Drew, E Elkord, B El-Rayes, MA Feitelson, DW Felsher, LR Ferguson, C Fimognari, GL Firestone, C Frezza, H Fujii, MM Fuster, D Generali, AG Georgakilas, F Gieseler, M Gilbertson, MF Green, B Grue, G Guha, D Halicka, WG Helferich, P Heneberg, P Hentosh, MD Hirschey, LJ Hofseth, RF Holcombe, K Honoki, HY Hsu, GS Huang, LD Jensen, WG Jiang, LW Jones, PA Karpowicz, WN Keith, SP Kerkar, GN Khan, M Khatami, YH Ko, O Kucuk, RJ Kulathinal, NB Kumar, BS Kwon, A Le, MA Lea, HY Lee, T Lichtor, LT Lin, JW Locasale, BL Lokeshwar, VD Longo, CA Lyssiotis, KL MacKenzie, M Malhotra, M Marino, ML Martinez-Chantar, A Matheu, C Maxwell, E McDonnell, AK Meeker, M Mehrmohamadi, K Mehta, GA Michelotti, RM Mohammad, SI Mohammed, DJ Morre, V Muralidhar, I Muqbil, MP Murphy, GP Nagaraju, R Nahta, E Niccolai, S Nowsheen, C Panis, F Pantano, VR Parslow, G Pawelec, PL Pedersen, B Poore, D Poudyal, S Prakash, M Prince, L Raffaghello, JC Rathmell, WK Rathmell, SK Ray, J Reichrath, S Rezazadeh, D Ribatti, L Ricciardiello, RB Robey, F Rodier, HPV Rupasinghe, GL Russo, EP Ryan, AK Samadi, I Sanchez-Garcia, AJ Sanders, D Santini, M Sarkar, T Sasada, NK Saxena, RE Shackelford, HMC Shantha Kumara, D Sharma, DM Shin, D Sidransky, MD Siegelin, E Signori, N Singh, S Sivanand, D Sliva, C Smythe, C Spagnuolo, DM Stafforini, J Stagg, PR Subbarayan, T Sundin, WH Talib, SK Thompson, PT Tran, H Ungefroren, MG Vander Heiden, V Venkateswaran, DS Vinay, PJ Vlachostergios, Z Wang, KE Wellen, RL Whelan, ES Yang, H Yang, X Yang, P Yaswen, C Yedjou, X Yin, J Zhu, M Zollo	01/12/2015
Evasion of anti-growth signaling: A key step in tumorigenesis and potential target for treatment and prophylaxis by natural compounds. Seminars in cancer biology	ARMR Amin, PA Karpowicz, TE Carey, J Arbiser, R Nahta, ZG Chen, JT Dong, O Kucuk, GN Khan, GS Huang, S Mi, HY Lee, J Reichrath, K Honoki, AG Georgakilas, A Amedei, A Amin, B Helferich, CS Boosani, MR Ciriolo, S Chen, SI Mohammed, AS Azmi, WN Keith, D Bhakta, D Halicka, E Niccolai, H Fujii, K Aquilano, SS Ashraf, S Nowsheen, X Yang, A Bilsland, DM Shin	01/12/2015
Cancer biomarkers. Molecular aspects of medicine	O Kucuk	01/11/2015
C-reactive protein in urologic cancers. Molecular aspects of medicine	J Huang, Y Baum, M Alemozaffar, K Ogan, W Harris, O Kucuk, VA Master	01/11/2015
Docetaxel-induced polyploidization may underlie chemoresistance and disease relapse. Cancer letters	A Ogden, PC Rida, BS Knudsen, O Kucuk, R Aneja	28/10/2015
Carotenoids and non-alcoholic fatty liver disease. Hepatobiliary surgery and nutrition	B Yilmaz, K Sahin, H Bilen, IH Bahcecioglu, B Bilir, S Ashraf, KJ Halazun, O Kucuk	01/06/2015
Sarcomatoid urothelial carcinoma of the bladder: a contemporary clinicopathologic analysis of 37 cases. The Canadian journal of urology	N Fatima, DJ Canter, BC Carthon, O Kucuk, VA Master, PT Nieh, K Ogan, AO Osunkoya	01/06/2015
Lycopene in the prevention of renal cell cancer in the TSC2 mutant Eker rat model. Archives of biochemistry and biophysics	K Sahin, B Cross, N Sahin, K Ciccone, S Suleiman, AO Osunkoya, V Master, W Harris, B Carthon, R Mohammad, B Bilir, K Wertz, CS Moreno, CL Walker, O Kucuk	15/04/2015
Die-hard survivors: heterogeneity in apoptotic thresholds may underlie chemoresistance. Expert review of anticancer therapy	A Ogden, PC Rida, MD Reid, O Kucuk, R Aneja	01/03/2015
Biweekly gemcitabine and paclitaxel in patients with relapsed or metastatic squamous cell carcinoma of the head and neck. Avicenna journal of medicine	A Sukari, M Al-Hajeili, M Salem, L Heilbrun, D Smith, G Yoo, JR Jacobs, HS Lin, O Kucuk	01/01/2015
Eugenol-rich Fraction of Syzygium aromaticum (Clove) Reverses Biochemical and Histopathological Changes in Liver Cirrhosis and Inhibits Hepatic Cell Proliferation. Journal of cancer prevention	S Ali, R Prasad, A Mahmood, I Routray, TS Shinkafi, K Sahin, O Kucuk	01/12/2014
Genistein protects hematopoietic stem cells against G-CSF-induced DNA damage. Cancer prevention research (Philadelphia, Pa.)	LR Souza, E Silva, E Calloway, O Kucuk, M Rossi, ML McLemore	01/05/2014
Enhancement of Cisplatin sensitivity in human cervical cancer: epigallocatechin-3-gallate. Frontiers in nutrition	U Kilic, K Sahin, M Tuzcu, N Basak, C Orhan, B Elibol-Can, E Kilic, F Sahin, O Kucuk	01/01/2014
External validation of the modified Glasgow prognostic score for renal cancer. Indian journal of urology : IJU : journal of the Urological Society of India	CG Tai, TV Johnson, A Abbasi, L Herrell, WB Harris, O Kucuk, DJ Canter, K Ogan, JG Pattaras, PT Nieh, VA Master	01/01/2014
Pomegranate extract inhibits the bone metastatic growth of human prostate cancer cells and enhances the in vivo efficacy of docetaxel chemotherapy. The Prostate	Y Wang, S Zhang, S Iqbal, Z Chen, X Wang, YA Wang, D Liu, K Bai, C Ritenour, O Kucuk, D Wu	23/12/2013
Wnt signaling blockage inhibits cell proliferation and migration, and induces apoptosis in triple-negative breast cancer cells. Journal of translational medicine	B Bilir, O Kucuk, CS Moreno	04/11/2013
Genistein enhances the efficacy of cabazitaxel chemotherapy in metastatic castration-resistant prostate cancer cells. The Prostate	S Zhang, Y Wang, Z Chen, S Kim, S Iqbal, A Chi, C Ritenour, YA Wang, O Kucuk, D Wu	01/11/2013
Epidermal growth factor promotes protein degradation of epithelial protein lost in neoplasm (EPLIN), a putative metastasis suppressor, during epithelial-mesenchymal transition. The Journal of biological chemistry	S Zhang, X Wang, S Iqbal, Y Wang, AO Osunkoya, Z Chen, Z Chen, DM Shin, H Yuan, YA Wang, HE Zhau, LW Chung, C Ritenour, O Kucuk, D Wu	18/01/2013
The effects of short-term genistein intervention on prostate biomarker expression in patients with localised prostate cancer before radical prostatectomy. The British journal of nutrition	B Lazarevic, C Hammarström, J Yang, H Ramberg, LM Diep, SJ Karlsen, O Kucuk, F Saatcioglu, KA Taskèn, A Svindland	28/12/2012
Lycopene counteracts the hepatic response to 7,12-dimethylbenz[a]anthracene by altering the expression of Bax, Bcl-2, caspases, and oxidative stress biomarkers. Pharmaceutical biology	CA Agca, M Tuzcu, H Gencoglu, F Akdemir, S Ali, K Sahin, O Kucuk	01/12/2012
Tomato powder impedes the development of azoxymethane-induced colorectal cancer in rats through suppression of COX-2 expression via NF-κB and regulating Nrf2/HO-1 pathway. Molecular nutrition & food research	M Tuzcu, A Aslan, Z Tuzcu, M Yabas, IH Bahcecioglu, IH Ozercan, O Kucuk, K Sahin	01/09/2012
Regulation of renal organic anion and cation transporters by thymoquinone in cisplatin induced kidney injury. Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association	R Ulu, A Dogukan, M Tuzcu, H Gencoglu, M Ulas, N Ilhan, I Muqbil, RM Mohammad, O Kucuk, K Sahin	01/05/2012
Genistein cooperates with the histone deacetylase inhibitor vorinostat to induce cell death in prostate cancer cells. BMC cancer	CJ Phillip, CK Giardina, B Bilir, DJ Cutler, YH Lai, O Kucuk, CS Moreno	11/04/2012
Preoperative Erythrocyte Sedimentation Rate Independently Predicts Overall Survival in Localized Renal Cell Carcinoma following Radical Nephrectomy. International journal of surgical oncology	BW Cross, TV Johnson, AB Derosa, K Ogan, JG Pattaras, PT Nieh, O Kucuk, WB Harris, VA Master	01/01/2012
Phase II Study of Gemcitabine and Docetaxel Combination in Patients with Previously Treated Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck. ISRN oncology	Z Kafri, LK Heilbrun, A Sukari, G Yoo, J Jacobs, HS Lin, H Mulrenan, D Smith, O Kucuk	01/01/2012
Dietary agents in cancer chemoprevention and treatment. Journal of oncology	JJ Raffoul, O Kucuk, FH Sarkar, GG Hillman	01/01/2012
PDGF upregulates Mcl-1 through activation of β-catenin and HIF-1α-dependent signaling in human prostate cancer cells. PloS one	S Iqbal, S Zhang, A Driss, ZR Liu, HR Kim, Y Wang, C Ritenour, HE Zhau, O Kucuk, LW Chung, D Wu	01/01/2012
EPLIN downregulation promotes epithelial-mesenchymal transition in prostate cancer cells and correlates with clinical lymph node metastasis. Oncogene	S Zhang, X Wang, AO Osunkoya, S Iqbal, Y Wang, Z Chen, S Müller, Z Chen, S Josson, IM Coleman, PS Nelson, YA Wang, R Wang, DM Shin, FF Marshall, O Kucuk, LW Chung, HE Zhau, D Wu	15/12/2011
Inhibitory effects of combination of lycopene and genistein on 7,12- dimethyl benz(a)anthracene-induced breast cancer in rats. Nutrition and cancer	K Sahin, M Tuzcu, N Sahin, F Akdemir, I Ozercan, S Bayraktar, O Kucuk	01/11/2011
Intratumor C-reactive protein as a biomarker of prognosis in localized renal cell carcinoma. The Journal of urology	TV Johnson, S Ali, A Abbasi, O Kucuk, WB Harris, K Ogan, J Pattaras, PT Nieh, FF Marshall, AO Osunkoya, VA Master	01/10/2011
Clinical trials of antioxidants as cancer prevention agents: past, present, and future. Free radical biology & medicine	M Goodman, RM Bostick, O Kucuk, DP Jones	01/09/2011
A tomato lycopene complex protects the kidney from cisplatin-induced injury via affecting oxidative stress as well as Bax, Bcl-2, and HSPs expression. Nutrition and cancer	A Dogukan, M Tuzcu, CA Agca, H Gencoglu, N Sahin, M Onderci, IH Ozercan, N Ilhan, O Kucuk, K Sahin	01/01/2011
Efficacy and safety of short-term genistein intervention in patients with localized prostate cancer prior to radical prostatectomy: a randomized, placebo-controlled, double-blind Phase 2 clinical trial. Nutrition and cancer	B Lazarevic, G Boezelijn, LM Diep, K Kvernrod, O Ogren, H Ramberg, A Moen, N Wessel, RE Berg, W Egge-Jacobsen, C Hammarstrom, A Svindland, O Kucuk, F Saatcioglu, KA Taskèn, SJ Karlsen	01/01/2011
Postoperative better than preoperative C-reactive protein at predicting outcome after potentially curative nephrectomy for renal cell carcinoma. Urology	TV Johnson, A Abbasi, A Owen-Smith, AN Young, O Kucuk, WB Harris, AO Osunkoya, K Ogan, J Pattaras, PT Nieh, FF Marshall, VA Master	01/09/2010
Cancer prevention with natural compounds. Seminars in oncology	NP Gullett, AR Ruhul Amin, S Bayraktar, JM Pezzuto, DM Shin, FR Khuri, BB Aggarwal, YJ Surh, O Kucuk	01/06/2010
Second international congress on nutrition and cancer. Nutrition and cancer	O Kucuk	01/01/2010
Perspectives for cancer prevention with natural compounds. Journal of clinical oncology : official journal of the American Society of Clinical Oncology	AR Amin, O Kucuk, FR Khuri, DM Shin	01/06/2009
Cancer-induced cachexia: a guide for the oncologist. Journal of the Society for Integrative Oncology	N Gullett, P Rossi, O Kucuk, PA Johnstone	01/01/2009
First International Congress on Nutrition and Cancer. Nutrition and cancer	O Kucuk	01/01/2009

Awards

Atlanta Magazine "Top Doctors," 2015-2019
Scientific and Technological Research Council of Turkey (TÜBİTAK) Science Award, 2018
Cancer Researcher of the Year Award, Gateway for Cancer Research, 2016
College Teaching Award, Wayne State University
President's Achievement Award for Community Research, Karmanos Cancer Institute
President's Achievement Award for Outstanding Service, Karmanos Cancer Institute
Faculty Research Excellence Award, School of Medicine, Wayne State University
Inaugural Director, Center for Integrative Health and Medicine, Emory University

Ratings & Reviews

Patients who are treated in outpatient and inpatient environments are eligible to receive a survey related to their individual care. Displayed ratings and reviews are displayed for Providers who have received at least 30 returned surveys over a 12-month period and are related to all Care Provider related survey questions. To help our patients better understand our Transparency program (ratings and review), the motivations behind it, how ratings are calculated, why ratings and reviews are not published for every EHC Provider, and how this information can be helpful for our patients, please click here.

4.9	One star One star One star One star One half star	Provider showed concern
4.8	One star One star One star One star One half star	Provider explained things clearly
4.8	One star One star One star One star One half star	Provider discussed treatment options
4.9	One star One star One star One star One half star	Provider included you in decisions
4.8	One star One star One star One star One half star	Likelihood of recommending this provider

View Reviews


One star One star One star One star One star	21/03/2024	Good
One star One star One star One star One star	21/03/2024	Dr. Kucuk is excellent- very consultative and thorough. I have several people to him.
One star One star One star One star One star	13/03/2024	Dr Kucuk is an excellent doctor. He is positive and gives me hope
One star One star One star One star One star	07/03/2024	Dr Kucuk is excellent. I have referred to a couple of my friends. Both of whom thanked me.
One star One star One star One star One star	28/02/2024	Great care!
One star One star One star One star One star	24/02/2024	Very well done & communicated!
One star One star One star One star One star	15/02/2024	Dr. Kucuk is awesome
One star One star One star One star One star	14/02/2024	All providers were professional and I did refer Dr Kucuk to a friend.
One star One star One star One star One half star	14/02/2024	Good
One star One star One star One star One star	10/02/2024	Dr Kucuk is a very thoughtful, caring and professional doctor
One star One star One star One star One star	08/02/2024	Could not have been better
One star One star One star One star One star	08/02/2024	Dr. Kucuk and entire staff are courteous, respectful, knowledgeable and supportive.
One star One star One star One star One star	07/02/2024	He was excellent
One star One star One star One star One star	07/02/2024	Dr. Kucuk spends a lot of time answering my questions and concerns regarding my treatment and care. Highly recommend him.
One star One star One star One star One star	25/01/2024	Utmost respect for care provider, am a long term patient
One star One star One star One star One star	18/01/2024	He's been my oncologist for 13 years. His care and concern are exemplary!
One star One star One star One star One star	17/01/2024	Dr. Kucuk is an excellent practitioner and human being.
One star One star One star One star One star	13/01/2024	Excellent suggestions and attentive to my concerns
One star One star One star One star One star	04/01/2024	Excellent care.
One star One star One star One star One star	28/12/2023	Dr Kucuk both knowledgeable & reassuring.
One star One star One star One star One star	27/12/2023	Dr kucuk I'm lucky to have him. For me he walks on water. He saved me and given me 15 more year plus of quality life
One star One star One star One star One star	20/12/2023	Feel fortunate to have Dr Kucuk manage my healthcare. He goes far beyond the standards of what you would expect. Irreplaceable!
One star One star One star One star One star	16/12/2023	Dr. Kucek Is outstanding!
One star One star One star One star One star	04/12/2023	Good
One star One star One star One star One star	29/11/2023	No surprises
One star One star One star One star One star	18/11/2023	I am very pleased with Dr. Kucuk and have been for several years. He is a truly nice person in addition to being an excellent physician.
One star One star One star One star One star	15/11/2023	Once again was given very helpful advice
One star One star One star One star One star	10/11/2023	Always good, never bad.
One star One star One star One star Empty star	10/11/2023	I sent a question as a message concerning lab results after the visit. I wish Dr. Kucuk would have answered my questions then rather than just schedule me for a follow up in 3 months without addressing the 2 questions till then. I'm not unhappy with Dr Kucuk mind you, but it would have been good to have him ease my mind concerning my 2 questions now.
One star One star One star One star One star	26/10/2023	Dr Kucuk has done an excellent job with my care. He is detailed and not in a hurry. He always explains things in a way that I can understand. I look forward to continued treatment from Dr. Kucuk and his staff.
One star One star One star One star One star	21/10/2023	He's been my medical oncologist for 12+ years! Superb care!
One star One star One star One star One star	18/10/2023	Do not lose Dr. Kucuk! He is a major asset your organization.
One star One star One star One star One star	18/10/2023	Dr Kucuk was excellent, caring, patient when answering my questions. I feel very comfortable with him providing my care.
One star One star One star One star One star	18/10/2023	Dr Kucuk was great
One star One star One star One star One star	12/10/2023	Exemplary
One star One star One star One star One star	12/10/2023	Good
One star One star One star One star One star	11/10/2023	Outstanding
One star One star One star One star One star	06/10/2023	Dr. Omer Kucuk is the best with my condition he always helps me at all times.
One star One star One star One star One star	05/10/2023	As always, Dr Kucuk answered all my questions and provided advice
One star One star One star One star One star	20/09/2023	Good staff
One star One star One star One star One star	06/09/2023	One of the best physician's visits I have ever had. Dr. Kucuk is great!
One star One star One star One star Empty star	30/08/2023	Good
One star One star One star One star One star	30/08/2023	And suggested ways to improve better
One star One star One star One star One star	24/08/2023	Dr Kucuk is an excellent physician who always takes the time to answer my questions. I would not want anyone else to treat me. I would highly recommend him to anyone seeking treatment for prostate cancer
One star One star One star One star One star	16/08/2023	Perfect physician
One star One star One star One star One star	16/08/2023	Could not have expected better spent the time and gave me valuable advice.
One star One star One star One star One star	26/07/2023	Dr. Kucuk is an excellent physician who takes time to explain everything and answers all my questions.
One star One star One star One star One star	26/07/2023	Excellent doctor and nurse
One star One star One star One star One star	03/07/2023	I've already recommended Dr Kucuk and Winship to others
One star One star One star One star One star	30/06/2023	Have recommended Emory many times over the 7 years I've been coming here during my stage 4 cancer cure. Praise Jesus and thanks to Omer kucuk
One star One star One star One star One star	01/06/2023	Professional and knows what he is doing
One star One star One star One star One half star	31/05/2023	Good
One star One star One half star Empty star Empty star	26/05/2023	Dr. Kucuk, incomprehensibly redundant. He repeatedly said that "if he were me," treatment should not be delayed__that if I wait too long, my situation "would be untreatable" (later rejected by Dr. Pattaras). Why the redundancy (in tandem with a stern, excessively serious expression? A form of scare tactic?.........
One star One star One star One star One star	25/05/2023	I've already recommended. Emory has the best customer service
One star One star One star One star One star	25/05/2023	Very good
One star One star One star One star One star	24/05/2023	Excellent
One star One star One star One star One star	13/05/2023	Dr. Kucuk is always very attentive and well-prepared.
One star One star One star One star One star	04/05/2023	Good
One star One star One star One star One star	28/04/2023	Dr. Kucuk is great and would recommend him highly.
One star One star One star One star One star	27/04/2023	Good
One star One star One star One star Empty star	21/04/2023	Overall Good
One star One star One star One star One star	06/04/2023	I've already recommended both Dr Kucuk and Winship ESJ to others
One star One star One star One star One star	01/04/2023	Dr Kucuk is very informative He answered all my questions in detail He is an excellent doctor I feel very comfortable with him and trust his judgement . I will recommend him highly to all family and friends
One star One star One star One star One star	22/03/2023	Dr Kucuk is a unique caring physician, who gives me great confidence in his recommendations
One star One star One star One star One star	22/03/2023	Dr. Kucuk is the best!
One star One star One star One star Empty star	03/03/2023	Good
One star One star One star One star One star	27/02/2023	Dr. Kucuk is an excellent physician!
One star One star One star One star One star	15/02/2023	Kucek is awesome
One star One star One star One star One star	10/02/2023	Dr Kucuk was professional, thoughtful and kind
One star One star One star One star One star	04/02/2023	Dr. Kucuk has always been consultative and involves me in all decisions.
One star One star One star One star One star	01/02/2023	Dr. Kucek was the best! Professional who explains procedures, methods, options, and follow-up care in terms easily understood. A great listener too!
One star One star One star One star One half star	27/01/2023	I'm very happy with my care, and treatment
One star One star One star One star One star	16/11/2022	Dr Kucuk is incredible. Warm , sensitive, knowledgeable, I have recommended him to many of my colleagues and friends who have the cancer I have.
One star One star One star One star One star	23/09/2022	Everyone was great, no surprises
One star One star One star One star One star	07/09/2022	Great interchange of ideas as always!
One star One star One star One star Empty star	31/08/2022	Good
One star One star One star One star Empty star	25/08/2022	My experience was generally very good, although I would have preferred a bit more detail all my diagnosis and treatment options. But I consider that my fault for not asking more questions.
One star One star One star One star One star	19/08/2022	Doctor was awesome
One star One star One star One star One star	13/08/2022	Always enjoy our conversations
One star One star One star One star One star	12/08/2022	Awesome. He took the time to make us feel he cared about the outcome of my husband's care.
One star One star One star One star One star	10/08/2022	We love Dr. Kucuk and have recommended him to others!
One star One star One star One star One star	26/06/2022	Good
One star One star One star One star One star	08/06/2022	Dr Kucuk is absolutely the most professional and competent Dr I have known.
One star One star One star One star One star	28/05/2022	Physician had excellent manner, and great knowledge base.
One star One star One star One star Empty star	25/05/2022	Good